ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
ExcepGen has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in August 2023.
ExcepGen's investors include Y Combinator, RA Capital Management, SV Angel, Oxonian Ventures, ZAKA VC.
ExcepGen is headquartered in San Francisco, United States.
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
ExcepGen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ExcepGen — Funding & Investors." VCBacked, August 24, 2023, https://www.vcbacked.co/company/excepgen. Accessed July 19, 2026.
VCBacked. (2023). ExcepGen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/excepgen
{{cite web |title=ExcepGen — Funding & Investors |url=https://www.vcbacked.co/company/excepgen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated